ccpm implementation in dr reddy’s...about dr reddy’s dr reddy’s laboratories limited...

21
1 © 2013 TOCICO. All rights reserved. TOCICO 2013 Conference CCPM Implementation in Dr Reddy’s Presented By: Ramakrishna, Mickey Tayeb Date: 06June2013

Upload: others

Post on 10-Mar-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

1© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

CCPM Implementation in Dr Reddy’s

Presented By: Ramakrishna, Mickey TayebDate: 06June2013

Page 2: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

2© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

About Dr Reddy’s

Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integratedpharmaceutical company, committed to providingaffordable and innovative medicines for healthier lives.

Core Businesses

Pharmaceutical Services and Active Ingredients

Global Generics

Proprietary Products

IPDO (Integrated Product Development Organization)

Page 3: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

3© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

About IPDO

• IPDO integrates all the R&D functions of Dr. Reddy’s tocreate synergy, deliver on time, and enhance capability indeveloping APIs and finished dosages.

• With project management driven product development andtechnical capabilities created ahead of competition, IPDOstrives to achieve targets that will make it a keydifferentiator for Dr. Reddy’s.

Page 4: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

4© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

2. What to Change?

3. What to Change to? 4. How to cause the change?

5. How to create POOGI?

1. Why Change?

Product Development CCPM way

Page 5: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

5© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Why change

Inconsistency in managing new product development• Many projects were missing the due dates.• Target dates are revised in the beginning of every financial

year.• Cycle times are high.• Throughput was inconsistent and skewed to the end of the

financial year (Hockey Stick syndrome).• Lack of process to assess the capacity of R&D• Stressed out resources due to missing due dates and more

projects in hand.

Page 6: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

6© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

What to change

Process of managing new product development Capacity definition

Project Planning

Project Execution

Project Review

Measurements

Page 7: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

7© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

What to change to

In 2008, Dr Reddy’s rolled out Viable Vision initiative andCCPM is implemented in New Product Development

• To build New Product Development as significantcompetitive edge.

Page 8: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

8© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

How to cause the change ..

Page 9: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

9© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

How to cause the change ..

Dr Reddy’s had formal project management organization andhence CCPM was rolled out very quickly.

Top management commitment was demonstrated in ensuringthe key stakeholders presence in all meetings, freezing of theprojects, accepting staggered dates, task updates, projectprogress reviews.

Dedicated team of experts created to do Full Kit and most ofthe projects are released with proper Full Kit.

Quick results obtained immediately after freezing increasedthe buy in of the stakeholders.

Page 10: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

10© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

How to cause the change ..

Facilitation team (FT) was created from resources within theorganization and dedicated for the implementation of CCPM.

FT helped in creating the templates, project plans, trainingof project managers, task managers and resourcemanagers.

Training, Handholding and mentoring by senior members ofGoldratt Schools enabled the Facilitation Team to bring inthe cultural change quickly and sustain.

Page 11: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

11© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Why POOGI

To sustain the initial results and continue the momentum.

To identify the flow blockers & improvement areas.

To do Buffer Management instead of crisis management.

Page 12: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

12© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

How to Create POOGI

Measuring the Flow

WIP Control

Buffer Indicators

Execution Analysis

Page 13: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

13© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Measuring the Flow

Page 14: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

14© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Designing the Process

• The different phases of the project development cycle are mapped

• Each phase, referred to as “bin”, is looked at separately and monitored.

Phase 1 Phase 2 Phase 4 Finished projectsFinished projectsPhase 3

Page 15: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

15© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Setting the Parameters

In each phase we monitor…

Projects that are waiting to start the phase – WIQ (Waiting In Queue). Note that WIQ in the first phase is Full kitted projects waiting for start

Projects that are in execution – WIP

Number of projects complete (per period)

The rate of project completion

Page 16: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

16© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Snapshot View (Fortnight)

4

9

4

11

3

5

12

2

Current WIP level

Waiting to start (WIQ)

Examine WIP and WIQ of each phase.• WIQ of Phase 4 is high. This is blocking the flow.• WIP of Phase 2 is higher than capacity of 8. It is leading

to bad multi tasking.

Jan-11 to Sep-11

Page 17: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

17© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Long Term View (Monthly)

• Examine the rate of completion of each phase.− Phase 4 Completion rate is low and WIQ is high− Improving FLOW in Phase 4 will increase throughput.

• This is where we should focus for next one month.• Function Head leads the improvement action.

59

610 5

153

36

1.0

19 47 8

0

JAN to SEP’11

0.53 1.3 0.22

Page 18: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

18© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

WIP Control

WIP is restricted within each portfolio instead of using staggering mechanism.

Page 19: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

19© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

What we monitor & review

ResultsDue Date PerformanceCycle TimeThroughputValue

RulesTask updationWIPRelease of New Projects

Portfolio HealthTotal Delay of Top 10 Projects% of Number of Red Projects% of 100% Buffer consumed Projects% Projects improved, Worsened, Not changed

Page 20: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

20© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Execution Analysis (RCA)

OPTIMISATION DELAY

POLYMORPH

Sampleavailability

P1

Form Stabilize

P2 P3P4

R&D PROCESS

Scalability & repeatability

P5

Processfinalisation

P7P8P9P4P10

MANPOWER

Resource used for another priority

P8P3

Analytical

Data /Spec generation

P1P3

Method finalisation

P6

Managementdecision

Priority Change

P5

Go/no go-CPP

P1

Page 21: CCPM Implementation in Dr Reddy’s...About Dr Reddy’s Dr Reddy’s Laboratories Limited (NYSE:RDY) is an integrated pharmaceutical company, committed to providing affordable and

21© 2013 TOCICO. All rights reserved.

TOCICO 2013 Conference

Results

Cycle Time Fillings DDPFrom To % From To % From To %

NA EU 800 450 -44% 20 36 +80% 30% 60% +100%

ROW 700 500 -28% 10 35 +250% 35% 78% +120%

API 450 350 -22% 20 25 +25% 60% 80% +33%